Sign in
CASBF Stock Price, Chart, Stats & News
CanSino Biologics Inc.
Save
CanSino Biologics Inc. (CASBF) does not currently pay a dividend.
1.61B
Market cap
–
Current P/E
–
Forward P/E
CASBF chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N. meningitides. It develops DTcP vaccine for infants and DTcP Booster vaccine, which are in Phase I clinical trial for addressing the weaker protection preventing pertussis after primary vaccination.
Similar securities
Based on sector and market capitalization
Report issue